However, our results also exhibited that other apoptotic signaling pathways, in addition to the mitochondrial Bax/Bcl-2 expression ratio, might be involved in the inhibition to PC-3 cell growth when tumor immunotherapy, such as SCM or MCM, was adopted (Table 1). The gene discussed is BCL2; the disease is neoplasm.